RxDoctor Payments Data

Sydney Murphy, PA

Physician Assistant · Charleston, SCNPI 1225624406

Payments from drug & device makers

$4,770in general payments, 2019–2025

Across 288 payments — averaging $16.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Merz North America, Inc.$636
  • Novo Nordisk$358
  • Exact Sciences$330
  • Amgen$291
  • Takeda Pharmaceuticals U.S.A., Inc.$158
  • plus $1K from 28 others

What the payments were for

  • Travel & lodging$3066%
  • Food & beverage$4,46494%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,770 in reported general payments places this provider in the 85th percentile of 1,852 physician assistant providers in South Carolina.

See all physician assistant providers in South Carolina

Medicare billing

Part B allowed, 2024
$2,588
Medicare patients
57
Services billed
129

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide171$172,791
MounjaroTirzepatide51$62,122
RybelsusSemaglutide28$39,402
EliquisApixaban35$23,330
KerendiaFinerenone30$23,070
JanuviaSitagliptin Phosphate26$22,286
JardianceEmpagliflozin17$21,524
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$19,702
MyrbetriqMirabegron19$15,685
Breo ElliptaFluticasone/Vilanterol26$15,658
UbrelvyUbrogepant12$15,438
XareltoRivaroxaban18$14,271
QuliptaAtogepant12$14,171
EntrestoSacubitril/Valsartan17$13,150
FarxigaDapagliflozin Propanediol20$12,567

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$358$212,192199 claims
Lilly USA, LLCMounjaro$30$62,12251 claims
GSKTrelegy Ellipta, Breo Ellipta$63$35,36045 claims
AbbVieUbrelvy, Qulipta, Synthroid$1,717$32,34665 claims
MerckJanuvia, Janumet Xr$16$29,88040 claims
PfizerEliquis$50$23,33035 claims
BayerKerendia$118$23,07030 claims
Boehringer IngelheimJardiance$56$21,52417 claims
Astellas Pharma US IncMyrbetriq$51$15,68519 claims
Johnson & JohnsonXarelto$27$14,27118 claims
NovartisEntresto$124$13,15017 claims
AstraZenecaFarxiga$45$12,56720 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,852 physician assistant providers in South Carolina.

Other physician assistant in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →